An evaluation of emerging vaccines for childhood pneumococcal pneumonia

Background Pneumonia is the leading cause of child mortality worldwide. Streptococcus pneumoniae (SP) or pneumococcus is estimated to cause 821,000 child deaths each year. It has over 90 serotypes, of which 7 to 13 serotypes are included in current formulations of pneumococcal conjugate vaccines tha...

Full description

Saved in:

Bibliographic Details
Published in:	BMC public health Vol. 11; no. Suppl 3; p. S26
Main Authors:	Webster, Julia, Theodoratou, Evropi, Nair, Harish, Seong, Ang Choon, Zgaga, Lina, Huda, Tanvir, Johnson, Hope L, Madhi, Shabir, Rubens, Craig, Zhang, Jian Shayne F, El Arifeen, Shams, Krause, Ryoko, Jacobs, Troy A, Brooks, Abdullah W, Campbell, Harry, Rudan, Igor
Format:	Journal Article
Language:	English
Published:	London BioMed Central 13.04.2011 Springer Nature B.V BMC
Subjects:	Biostatistics Child Cost-Benefit Analysis Developing countries Developmental stages Disease Environmental Health Epidemiology Global Health Health sciences Humans Industrialized nations International policy LDCs Medicine Medicine & Public Health Mortality Nutrition research Pharmaceutical industry Pneumococcal Vaccines - economics Pneumonia Pneumonia, Pneumococcal - mortality Pneumonia, Pneumococcal - prevention & control Proteins Public Health Regulatory approval Streptococcus infections Streptococcus pneumoniae - immunology Systematic review Vaccine Vaccines Vaccines, Conjugate - economics Bangladesh United States > US Asia Africa Croatia Pneumococcal Disease Invasive Pneumococcal Disease Vaccine Serotypes Pneumococcal Conjugate Vaccine Pneumococcal Pneumonia
ISSN:	1471-2458, 1471-2458
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!